NCT05306366View on ClinicalTrials.gov

A Brain Imaging PET Study of [11C]-Lu AF90103 in Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

March 23, 2022

Primary Completion Date

June 7, 2022

Study Completion Date

June 7, 2022

Conditions

Healthy Young Men

Interventions

DRUG

[11C]-Lu AF90103

PET ligand administrated as a single intravenous bolus injection

Trial Locations (1)

141 86

Karolinska Trial Alliance, Huddinge

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY